Prepregnancy Body Mass Index and Serum C-Peptide as Complementary Predictors of Insulin Requirement in Gestational Diabetes Mellitus: A Retrospective Cohort Study

Abstract Purpose: To identify routinely available factors associated with insulin requirement in women with gestational diabetes mellitus (GDM), focusing on prepregnancy body mass index (BMI) and serum C-peptide as clinical proxies of insulin resistance and β-cell secretory capacity. Methods: Retrospective cohort of 110 women with GDM meeting standard 75-g glucose tolerance test criteria, followed at a tertiary internal medicine clinic in Istanbul, Türkiye (2020–2023). Insulin was started when glycaemic targets were not met with medical nutrition therapy. Associations were examined by multivariable logistic regression with bootstrap validation. Results: Insulin was required in 45 women (40.9%), rising from 13.6% to 52.8% across prepregnancy BMI categories (P for trend = 0.003). After adjustment for age, glucose tolerance test values, HbA1c and referral timing, higher prepregnancy BMI (adjusted odds ratio [aOR] 1.18 per kg/m2; 95% confidence interval [CI] 1.06–1.31) and lower C-peptide (aOR 3.42 per halving; 95% CI 1.67–6.97) were independently associated with insulin requirement. Insulin need was 71.4% in women with both obesity and below-median C-peptide versus 8.7% in those with neither (aOR 24.5; 95% CI 4.3–139.7). Adding C-peptide increased the area under the curve from 0.76 to 0.82 (optimism-corrected 0.78). Insulin-treated women had more preterm births (aOR 6.01; 95% CI 1.01–35.65) and accounted for all cases of macrosomia. Conclusion: Prepregnancy BMI and C-peptide appear to capture complementary insulin-resistance and insulin-secretory pathways to insulin requirement in GDM. Combining these inexpensive measures at diagnosis may help identify women likely to need insulin; prospective validation is warranted.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11465737/v1
Primary Topic
Gestational Diabetes Research and Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Prepregnancy Body Mass Index and Serum C-Peptide as Complementary Predictors of Insulin Requirement in Gestational Diabetes Mellitus: A Retrospective Cohort Study

Oğuz Fırat Bozkurt, Seydahmet Akın, Hande Erman, Banu Böyük
3 links
Research Square
Gestational Diabetes Research and Management
preprint

Prepregnancy Body Mass Index and Serum C-Peptide as Complementary Predictors of Insulin Requirement in Gestational Diabetes Mellitus: A Retrospective Cohort Study

Oğuz Fırat Bozkurt, Seydahmet Akın, Hande Erman, Banu Böyük
preprint en

Abstract

Abstract Purpose: To identify routinely available factors associated with insulin requirement in women with gestational diabetes mellitus (GDM), focusing on prepregnancy body mass index (BMI) and serum C-peptide as clinical proxies of insulin resistance and β-cell secretory capacity. Methods: Retrospective cohort of 110 women with GDM meeting standard 75-g glucose tolerance test criteria, followed at a tertiary internal medicine clinic in Istanbul, Türkiye (2020–2023). Insulin was started when glycaemic targets were not met with medical nutrition therapy. Associations were examined by multivariable logistic regression with bootstrap validation. Results: Insulin was required in 45 women (40.9%), rising from 13.6% to 52.8% across prepregnancy BMI categories (P for trend = 0.003). After adjustment for age, glucose tolerance test values, HbA1c and referral timing, higher prepregnancy BMI (adjusted odds ratio [aOR] 1.18 per kg/m2; 95% confidence interval [CI] 1.06–1.31) and lower C-peptide (aOR 3.42 per halving; 95% CI 1.67–6.97) were independently associated with insulin requirement. Insulin need was 71.4% in women with both obesity and below-median C-peptide versus 8.7% in those with neither (aOR 24.5; 95% CI 4.3–139.7). Adding C-peptide increased the area under the curve from 0.76 to 0.82 (optimism-corrected 0.78). Insulin-treated women had more preterm births (aOR 6.01; 95% CI 1.01–35.65) and accounted for all cases of macrosomia. Conclusion: Prepregnancy BMI and C-peptide appear to capture complementary insulin-resistance and insulin-secretory pathways to insulin requirement in GDM. Combining these inexpensive measures at diagnosis may help identify women likely to need insulin; prospective validation is warranted.

Research Square
Istanbul Medipol University (TR), Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR), Sağlık Bilimleri Üniversitesi (TR)
Good health and well-being
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon